Fay no longer works for the University of Manchester Innovation Factory.

Please contact either of the below mailboxes with your query:

Licensing:

Licensing@uominnovationfactory.com

Investment:

Investment@uominnovationfactory.com

Fay's involvement

Prof. Lydia Tabernero in the lab - Innovation Factory

Health and BiotechLife SciencesPharma

TaBriX- Innovative solutions for anti-infective therapies

TaBriX - Developing innovative solutions to create anti-infectives for the future.

Life SciencesMedtech

InPepCide - Fungal keratitis treatment

Damage to the eye as a result of fungal infection remains a pressing issue, with early intervention not always being possible and long-term vision loss being common. This new technology can be the quick and accurate intervention needed to prevent permanent impairment.

Health and Biotech

Light sight

A light receptor with frequency-dependent activation level.
Investment-Ready

Life SciencesMedtech

The cellular level – eNAMPT stimulation

A build-up of Nicotinamide Adenine Dinucleotide (NAD) in the body can result in the onset of various diseases and poor health outcomes. The University of Manchester have developed a new series of small molecule compounds, specifically designed to stimulate eNAMPT dimerization and have demonstrated these have potent activity leading to a corrective effect in in vitro and in vivo phenotypic models of diabetes. These could also have benefits in the treatment of a number of other diseases.